🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Alignment healthcare CFO sells over $1 million in company stock

Published 07/19/2024, 08:23 PM
ALHC
-

Investors following Alignment Healthcare, Inc. (NASDAQ:ALHC) might be interested to learn that the company's Chief Financial Officer, Robert Thomas Freeman, has recently sold a significant amount of company stock. Over a span of three days, Freeman sold a total of 105,000 shares, resulting in proceeds exceeding $1 million.

The transactions, which took place from July 17 to July 19, saw Freeman dispose of shares at prices ranging from $10.0003 to $10.0054. On July 17, a total of 22,100 shares were sold, followed by a sale of 44,042 shares on July 18, and finally, 38,858 shares on July 19. These sales amounted to a collective value of approximately $1,050,236.

It's worth noting that the shares sold by Freeman are held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust for which Mr. Freeman is an indirect beneficiary. This detail was disclosed in a footnote in the SEC filing, emphasizing the relationship between the executive and the owner of the shares.

Despite the recent sales, Freeman still retains a substantial interest in the company, with ownership of 414,429 shares following the last transaction reported. These remaining shares indicate a continued vested interest in the company's performance and alignment with shareholder values.

As Chief Financial Officer, Freeman's transactions are closely watched by investors seeking insights into the financial health and insider perspective of Alignment Healthcare. The company, which operates in the hospital and medical service plans industry, is incorporated in Delaware and has its business address in Orange, California.

For investors keeping track of insider transactions, such activity can offer valuable context when assessing a company's stock performance and potential future direction.

In other recent news, Alignment Healthcare has reported significant growth in its Q1 2024 earnings, with a 50% increase in health plan membership and a 43% rise in total revenue. The company has also amended its corporate charter, following a stockholders' vote on several proposals, including officer exculpation and the election of Class III directors. In addition, BofA Securities upgraded Alignment Healthcare's stock from Neutral to Buy, citing improved visibility into the company's margin progression. Simultaneously, Piper Sandler also upgraded the stock from Neutral to Overweight, following the company's robust first-quarter results and revised full-year 2024 guidance. These developments reflect the company's strategic shift towards improving margins and its commitment to transparency with its stockholders.

InvestingPro Insights

Amid the notable insider trading activity at Alignment Healthcare, Inc. (NASDAQ:ALHC), investors may find additional context through key metrics and insights from InvestingPro. The company's market capitalization stands at $1.92 billion, suggesting a significant presence in the healthcare sector. Notably, the stock has seen a substantial return over the last year, with a 73.32% increase, and the momentum appears to continue with a 13.53% return over the last week, signaling strong recent performance.

From an analytical perspective, the Price / Book ratio for the last twelve months as of Q1 2024 is high at 14.71, which could indicate that the stock is trading at a premium compared to its book value. Furthermore, analysts have revised their earnings downwards for the upcoming period, which may warrant caution for prospective investors. The high Price / Book multiple, coupled with the recent insider sales, could be of interest to those evaluating the company's valuation.

For those looking to delve deeper into Alignment Healthcare's financials and forecasts, there are additional InvestingPro Tips available that provide a comprehensive view of the company's performance and market position. For example, the company is not expected to be profitable this year, and it operates with a moderate level of debt. These factors, among others, can be pivotal in making informed investment decisions.

Investors interested in further analysis and insights can access a wealth of additional InvestingPro Tips for Alignment Healthcare by visiting https://www.investing.com/pro/ALHC. Plus, use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, unlocking even more valuable investment information.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.